Todd Harris, Chief Executive Officer at Tyra Biosciences, Inc. (TYRA), sold 5,912 shares at $16.00 ($95K) on 2023-03-28, disclosed to the SEC on 2023-03-28.
Scheduled sale ($95k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 170 | $3K | 2.9% |
| 2 | $16.00 | 2,963 | $47K | 50.1% |
| 3 | $16.00 | 2,779 | $44K | 47.0% |
| Total | $16.00 avg | 5,912 | $95K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |